Are IMRT treatments in the head and neck region increasing the risk of secondary cancers?

References

• Hall EJ, Wuu CS. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83–8.
   PubMed Web of Science ®Google Scholar
• Dasu A, Toma-Dasu I, Olofsson J, Karlsson M. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 2005;44:339–47.
   PubMed Web of Science ®Google Scholar
• Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1–7.
   PubMed Web of Science ®Google Scholar
• Boice Jr. JD, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992;326:781–5.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F et al. Breast cancer and other second neoplasms after childhood Hodgkin’s disease. N Engl J Med 1996;334:745–51.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000;88:398–406.
   PubMed Web of Science ®Google Scholar
• Grantzau T, Mellemkjær L, Overgaard J. Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG). Radiother Oncol 2013;106:42–9.
   PubMed Web of Science ®Google Scholar
• Followill D, Geis P, Boyer A. Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. Int J Radiat Oncol Biol Phys 1997;38:667–72.
   PubMed Web of Science ®Google Scholar
• Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:1195–203.
   PubMed Web of Science ®Google Scholar
• Schneider U. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry et al. (Int J Radiat Oncol Biol Phys 2005 ;62:1195–203). Int J Radiat Oncol Biol Phys 2006;64:1290.
   PubMed Web of Science ®Google Scholar
• Ruben JD, Lancaster CM, Jones P, Smith RL. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: Implications for carcinogenesis. Int J Radiat Oncol Biol Phys 2011;81:1458–64.
   PubMed Web of Science ®Google Scholar
• Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol 2014; 110:471–6.
   PubMed Web of Science ®Google Scholar
• Hall EJ. Henry S. Kaplan distinguished scientist award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis. Int J Radiat Biol 2004;80:327–37.
   PubMed Web of Science ®Google Scholar
• ICRP. ICRP Publication 103: The 2007 recommendations of the International Commission on Radiological Protection. Ann ICRP 2007;37:1–332.
   Google Scholar
• Palm A, Nilsson E, Herrnsdorf L. Absorbed dose and dose rate using the Varian OBI 1.3 and 1.4 CBCT system. J Appl Clin Med Phys 2010;11:3085.
   PubMedGoogle Scholar
• Quinn A, Holloway L, Hardcastle N, Tomé WA, Rosenfeld A, Metcalfe P. Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy. Radiother Oncol 2013; 108:266–8.
   PubMed Web of Science ®Google Scholar
• Schneider U, Kaser-Hotz B. A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. Z Med Phys 2005;15:31–7.
   PubMedGoogle Scholar
• Davis RH. Production and killing of second cancer precursor cells in radiation therapy: In regard to Hall and Wuu (Int J Radiat Oncol Biol Phys 2003;56:83–8). Int J Radiat Oncol Biol Phys 2004;59:916.
   PubMed Web of Science ®Google Scholar
• Schneider U. Dose-response relationship for radiation- induced cancer – decrease or plateau at high dose: In regard to Davis (Int J Radiat Oncol Biol Phys 2004;59:916). Int J Radiat Oncol Biol Phys 2005;61:312–3.
   PubMed Web of Science ®Google Scholar
• Schneider U, Stipper A, Besserer J. Dose-response relationship for lung cancer induction at radiotherapy dose. Z Med Phys 2010;20:206–14.
   PubMed Web of Science ®Google Scholar
• De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after small radiation volumes. J Clin Oncol 2009;27 :4239–46.
   PubMed Web of Science ®Google Scholar
• Ruben JD, Davis S, Evans C, Jones P, Gagliardi F, Haynes M, et al. The effect of intensity-modulated radiotherapy on radiation-induced second malignancies. Int J Radiat Oncol Biol Phys 2008;70:1530–6.
   PubMed Web of Science ®Google Scholar
• Brodin NP, Vogelius IR, Maraldo MV, Munck af Rosenschöld P, Aznar MC, Kiil-Berthelsen A, et al. Life years lost—comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer 2012;118:5432–40.
   PubMed Web of Science ®Google Scholar
• Expósito MR, Sánchez-Nieto B, Terrón JA, Domingo C, Gómez F, Sánchez-Doblado F. Neutron contamination in radiotherapy: Estimation of second cancers based on measurements in 1377 patients. Radiother Oncol 2013;107: 234–41.
   PubMed Web of Science ®Google Scholar
• Dasu A, Toma-Dasu I, Franzén L, Widmark A, Nilsson P. Secondary malignancies from prostate cancer radiation treatment: A risk analysis of the influence of target margins and fractionation patterns. Int J Radiat Oncol Biol Phys 2011;79:738–46.
   PubMed Web of Science ®Google Scholar
• Vanhavere F, Huyskens D, Struelens L. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. Radiat Prot Dosimetry 2004;110: 607–12.
   PubMed Web of Science ®Google Scholar
• Josteen A, Matzinger O, Jeanneret-Sozzi W, Bochud F, Moeckli R. Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/ superposition algorithms: Implications for secondary cancer risk assessment. Radiother Oncol 2013; 106:33–41.
   PubMed Web of Science ®Google Scholar
• Gudowska I, Ardenfors O, Toma-Dasu I, Dasu A. Radiation burden from secondary doses to patients undergoing radiation therapy with photons and light ions and radiation doses from imaging modalities. Radiat Prot Dosimetry Epub 2013 Dec 18.
   Google Scholar
• Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006;80:263–7.
   PubMed Web of Science ®Google Scholar